Skip to content

To Assess the Anti-adhesive Effect and Safety of Protescal

To Assess the Anti-adhesive Effect and Safety of Protescal Following Laparoscopic Surgery

Status
Terminated
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01810900
Enrollment
50
Registered
2013-03-14
Start date
2012-09-30
Completion date
2013-12-31
Last updated
2016-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Laparoscopic Myomectomy

Keywords

anti-adhesive effect and safety, laparoscopic myomectomy

Brief summary

This multicenter, randomized, single-blind study assessed the safety and efficacy of Protescal for the reduction of post-operative adhesion formation following myomectomy.

Detailed description

The age of the patients participating in the study overed 20 years and included nonpregnant women requiring laparoscopic myomectomy and expected to undergo a second-look laparoscopy as part of their treatment plan 5 weeks after the initial surgery.

Interventions

DEVICEProtescal

Sponsors

LG Life Sciences
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
20 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* a woman who is over 20 years old * a woman who needs a laparoscopic myomectomy

Exclusion criteria

* a pregnant woman and a nursing mother

Design outcomes

Primary

MeasureTime frame
presence/absence of postoperative adhesions at second-look procedureat second look laparoscopy after 5 weeks later initial laparoscopic myomectomy

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026